PrednisoloneGlucocorticoidsBone and BonesDexamethasoneBone RemodelingBone DensityReceptors, GlucocorticoidAnti-Inflammatory AgentsBone ResorptionBone MarrowHydrocortisoneBone DevelopmentMifepristoneBone Marrow CellsBone NeoplasmsMethylprednisoloneBone DiseasesCorticosteroneAdrenalectomyBone RegenerationBone MatrixAzathioprineBone Marrow TransplantationBetamethasoneBone TransplantationImmunosuppressive AgentsDrug Therapy, Combination11-beta-Hydroxysteroid Dehydrogenase Type 1Hormone AntagonistsCortisone11-beta-Hydroxysteroid DehydrogenasesTriamcinolone11-beta-Hydroxysteroid Dehydrogenase Type 2Fractures, BoneAdministration, OralBone SubstitutesPulse Therapy, DrugRNA, MessengerBone Diseases, MetabolicTime FactorsCells, CulturedOsteoporosisDose-Response Relationship, DrugPrednisonePituitary-Adrenal SystemBone Morphogenetic ProteinsBell PalsyHypothalamo-Hypophyseal SystemOsteogenesisTreatment OutcomeBone Morphogenetic Protein 2Adrenal Cortex HormonesGene Expression RegulationOsteoblastsAdrenocorticotropic HormoneTriamcinolone AcetonideFemurTemporal BoneHydroxysteroid DehydrogenasesDouble-Blind MethodNephrotic SyndromeBeclomethasoneBudesonideMineralocorticoidsCyclophosphamideParietal BoneArthritis, RheumatoidTablets, Enteric-CoatedOsteoclastsCyclosporinePregnenedionesDrug Administration ScheduleMetyraponeOsteocalcinMice, Inbred C57BLCell LineAntirheumatic AgentsAlkaline PhosphataseReceptors, MineralocorticoidLiverAlveolar Bone LossBone CementsRats, Sprague-DawleyTibiaAnnexin A111-HydroxycorticosteroidsOsteocytesBone CystsAsthmaTranscription, GeneticCell DifferentiationVincristineRats, WistarEnemaAdministration, TopicalTyrosine TransaminaseCalcification, PhysiologicSteroidsIsonipecotic AcidsPolymyalgia Rheumatica